Inhibition of HIF-1α by Atorvastatin During 131 I-RTX Therapy in Burkitt's Lymphoma Model

Radioimmunotherapy (RIT) serves as a targeted therapy for non-Hodgkin lymphomas (NHL). Although HIF(Hypoxia-inducible factors)-1α is an important biomarker during radiation therapy, its role in NHL is unclear. Atorvastatin (ATV) is used as a combination drug for chemotherapy. We investigated whether...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancers 2020-05, Vol.12 (5)
Hauptverfasser:	Kim, Eun-Ho, Ko, Hae Young, Yu, A Ram, Kim, Hyeongi, Zaheer, Javeria, Kang, Hyun Ji, Lim, Young-Cheol, Cho, Kyung Deuk, Joo, Hyun-Yoo, Kang, Min Kyoung, Lee, Jae Jun, Lee, Seung-Sook, Kang, Hye Jin, Lim, Sang Moo, Kim, Jin Su
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!